HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Expert Panel Nears Ingredient Review Milestone

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel has reviewed the safety of nearly half of all ingredients in use in cosmetic products, CIR Director Alan Andersen said during the group’s December meeting.

You may also be interested in...



What Now? US Cosmetic Review Has Evaluated Up To 91% Of Ingredients Used Nationwide

CIR’s work is far from done, says executive director Bart Heldreth, citing the cosmetics industry's vibrant innovation tradition and ingredient re-review needs that should keep the program sufficiently busy.

Gill To Take CIR Director Role With Andersen’s Exit

CIR Deputy Director Lillian Gill will replace Alan Andersen as director this summer, the group reported at its March 18-19 meeting. Gill was chosen because of her “hard-nosed” approach to regulation, says Andersen, who added that he will be available for some time as a consultant.

CIR Panel Affirms Paraben Safety, Will Investigate Infant Skin Properties

With parabens’ use in infant products coming under scrutiny abroad, the CIR Expert Panel intends to learn more about how infant skin reacts to personal-care products. However, the panel maintains its 2006 “safe as used” assessment for parabens.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel